M
M. Ravi
Researcher at Sathyabama University
Publications - 22
Citations - 356
M. Ravi is an academic researcher from Sathyabama University. The author has contributed to research in topics: Macrobrachium rosenbergii & Biology. The author has an hindex of 8, co-authored 16 publications receiving 254 citations. Previous affiliations of M. Ravi include C. Abdul Hakeem College.
Papers
More filters
Journal ArticleDOI
Synthesis and characterization of CS/TPP nanoparticles for oral delivery of gene in fish
TL;DR: Results indicate that DNA can be easily delivered into fish by feeding with CS/TPP nanoparticles, as shown by immunohistochemistry, ELISA and real-time PCR analyses.
Journal ArticleDOI
Studies on the occurrence of white tail disease (WTD) caused by MrNV and XSV in hatchery-reared post-larvae of Penaeus indicus and P. monodon
M. Ravi,A. Nazeer Basha,M. Sarathi,H.H. Rosa Idalia,J. Sri Widada,J R Bonami,A.S. Sahul Hameed +6 more
TL;DR: White tail disease (WTD) caused by Macrobrachium rosenbergii nodavirus (MrNV) and extra small viruses (XSV) is a major problem and has been observed in hatchery reared post-larvae of marine shrimp (Penaeus monodon and P. indicus).
Journal ArticleDOI
Clearance of white spot syndrome virus (WSSV) and immunological changes in experimentally WSSV-injected Macrobrachium rosenbergii
TL;DR: Immunological parameters such as proPO, O(2)(-) and clotting time in WSSV-injected M. rosenbergii were found to be significantly higher than those of the control groups, whereas THC and superoxide dismutase were significantly lower when compared to control groups.
Journal ArticleDOI
Efficacy of bacterially expressed dsRNA specific to different structural genes of white spot syndrome virus (WSSV) in protection of shrimp from WSSV infection.
M. Sarathi,Martin Simon,C. Venkatesan,John Thomas,M. Ravi,N. Madan,S Thiyagarajan,A.S. Sahul Hameed +7 more
TL;DR: The use of an RNase III-deficient strain of E. coli HT115(DE3) to produce bacterially derived dsRNAs specific to different structural genes of WSSV other than VP28 is reported, which opens the possibility of developing dsRNA based antiviral therapeutics for commercial use.
Journal ArticleDOI
Clearance of Macrobrachium rosenbergii nodavirus (MrNV) and extra small virus (XSV) and immunological changes in experimentally injected Macrobrachium rosenbergii
TL;DR: These 2 viruses failed to cause mortality or clinical signs of disease in injected adult prawns during the experimental period of 100 days and significant differences in some of the immunological parameters were found in the early days p.i. and became insignificant in the later days.